Junior faculty members at Ohio State have received two of the three Career Development Awards that the Sarcoma Alliance for Research through Collaboration (SARC) issues annually to support sarcoma research by new investigators. The 2014 awardees include David Liebner, MD, and James L. Chen, MD.
Liebner (left), an assistant professor in the Department of Internal Medicine (Division of Medical Oncology) and in the Department of Biomedical Informatics, has clinical expertise in sarcoma and melanoma, and a research focus in cancer bioinformatics. He has been involved with many clinical trials spanning a variety of fields. His research vision is to develop and leverage computational tools to improve prognostic and predictive models in sarcoma and melanoma.
Chen (right), an assistant professor in the Department of Biomedical Informatics and in the Department of Internal Medicine (Division of Medical Oncology), has been involved in genomics and complex computational modeling of biological data for nearly a decade. He is interested in the personalization of medicine through the development of biomarkers for molecular pathway activation using automated genomic techniques. These biomarkers may help clinicians customize treatment regimens for sarcoma and other cancers.
SARC is a not-for-profit consortium representing physician clinician/scientists from several institutions who are dedicated to cooperative research that leads to new treatments for patients with sarcoma, a cancer of the bone and connective tissue.